Literature DB >> 30281807

Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.

Mingxia Li1, Xinxin Du1, Menghan Lu1,2, Weiyi Zhang1, Zhihui Sun1, Lian Li1, Mingxia Ye1, Wensheng Fan1, Shufang Jiang1, Aijun Liu3, Min Wang1,4, Yuanguang Meng1, Yali Li1.   

Abstract

We assessed the prevalence characteristics of single and multiple high-risk human papillomavirus (HR-HPV) infections. A total of 1783 women who underwent colposcopy and cervical biopsy for abnormal ThinPrep Cytology Test and/or HR-HPV subtype genotyping results were enrolled in the study. Among the participants, 770 were diagnosed with cervicitis, 395 with cervical intraepithelial neoplasia grade 1 (CIN1), 542 with CIN2-3, and 76 with squamous cell carcinoma (SCC), with HR-HPV infection rates of 75.8%, 85.8%, 95.9%, and 88.4%, respectively. The prevalence of total and multiple HR-HPV infections exhibited a bimodal age distribution with a peak at ≤25 years, a decline with age and a second peak at ≥55 years, whereas single HR-HPV infections exhibited one peak from 35 to 44 years. The four most dominant HPV genotypes were HPV 16 (29.5%), 52 (15.0%), 58 (14.2%), and 18 (10.4%). In total, 67.0%, 70.4%, and 82.1% of patients with CIN1, CIN2-3, and SCC, respectively, had a single HR-HPV infection, which increased significantly with the aggravation of the cervical lesion grade (P = 0.045). Patients with a single HPV 16 infection had higher incidences of CIN2+ (62.2%) than those with multiple HPV 16 infections (52.4%) (P = 0.021). Patients coinfected with HPV 16 had higher CIN2+ incidence than those with single HPV 52, 31, 33, 35, 39, 45, 51, 56, or 59 infections (P < 0.001). This study provided baseline data on the prevalence characteristics of single and multiple HR-HPV infections in women attending a gynecological outpatient clinic in Beijing.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical cancer; genotyping; high-risk human papillomavirus (HR-HPV); prevalence

Mesh:

Year:  2018        PMID: 30281807     DOI: 10.1002/jmv.25331

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.

Authors:  Jiao Li; Juan-Juan Gao; Na Li; Ya-Wen Wang
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

2.  Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.

Authors:  Tofan Widya Utami; Andrijono Andrijono; Andi Putra; Junita Indarti; Gert Fleuren; Ekaterina Jordanova; Inas Humairah; Ahmad Utomo
Journal:  Clin Exp Vaccine Res       Date:  2022-05-31

3.  Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China.

Authors:  Xiangpeng Wang; Yuan Song; Xiaofei Wei; Guanyu Wang; Ruili Sun; Mingyong Wang; Lijun Zhao
Journal:  Virol J       Date:  2022-01-06       Impact factor: 4.099

4.  Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study.

Authors:  Jaehyun Seong; Sangmi Ryou; JeongGyu Lee; Myeongsu Yoo; Sooyoung Hur; Byeong-Sun Choi
Journal:  Virol J       Date:  2021-09-17       Impact factor: 4.099

5.  Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016-2020.

Authors:  Xiaotian Yan; Lingwei Shen; Yufei Xiao; Qi Wang; Fugang Li; Yun Qian
Journal:  Virol J       Date:  2021-10-20       Impact factor: 4.099

6.  Genotype-specific Distribution and Change of High-risk Human Papillomavirus Infection and the Association with Cervical Progression Risk in Women with Normal Pathology and Abnormal Cytology in a Population-based Cohort Study in China.

Authors:  Haixia Jia; Ling Ding; Yang Han; Yuanjing Lyu; Min Hao; Zhiqiang Tian; Jintao Wang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

Review 7.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.

Authors:  Chichao Xia; Sile Li; Teng Long; Zigui Chen; Paul K S Chan; Siaw Shi Boon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

8.  Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.

Authors:  Arsenio Spinillo; Mattia Dominoni; Anna C Boschi; Cecilia Sosso; Giacomo Fiandrino; Stefania Cesari; Barbara Gardella
Journal:  J Oncol       Date:  2020-10-26       Impact factor: 4.375

9.  Analysis of Distributions of HPV Infection in Females with Cervical Lesions in the Western District of Beijing Chaoyang Hospital.

Authors:  Meili Gong; Chen Chen; Huirong Zhao; Liyuan Guo; Mingxia Sun; Meiyu Song
Journal:  J Healthc Eng       Date:  2022-03-14       Impact factor: 2.682

10.  Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.

Authors:  Yanfang Li; Hairu Wang; Yanjun Zhang; Xuan Jing; Nan Wu; Yabin Hou; Chonghua Hao
Journal:  Int J Gynaecol Obstet       Date:  2020-10-22       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.